Just a little way down the hill from Huntsman Cancer Institute, the Zangle Lab in the Department of Chemical Engineering is working on new technologies to choose the most effective therapies for each individual patient with breast cancer. We are excited about a project that takes a new approach to measure the growth of cancer cells and predict which drugs may be most beneficial to patients with advanced metastatic breast cancer.
"cancer research" News
By unraveling the link between obesity and gastrointestinal cancers, researchers hope to develop effective treatments and strategies for lowering cancer risk. A team of scientists at Huntsman Cancer Institute published a wide review of findings on the biological links between obesity and gastrointestinal cancers. They also examined studies on how diet, exercise, and other weight-related interventions may help reverse this connection.
African American men experience significant health disparities. They are almost twice as likely to be diagnosed with prostate cancer as white men, yet they are underrepresented in prostate cancer research. A new study by Charles R. Rogers, PhD, MPH, MS, CHES®, uncovers attitudes toward prostate cancer research among African American men and suggests strategies to increase participation in research. The study is included in a new collection of research on health disparities impacting African American men.
Women who reported recent, regular use of low-dose aspirin had a 23% lower risk of ovarian cancer when compared with women who did not regularly take aspirin, according to research led by Mollie Barnard, ScD, a postdoctoral fellow at Huntsman Cancer Institute.
Dear patients, please know this as you go through your treatment journey: the dedicated technical staff, PhD students, and postdoctoral fellows in Dr. Alana Welm's lab continue to work hard every day (and night!) to bring new hope to breast cancer through innovative research, always with patients in mind.
Huntsman Cancer Institute established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Ignacio Garrido-Laguna, MD, PhD, is a physician-scientist who treats patients with pancreatic cancer.
Every year, we open our doors to share our mission and educate our community about cancer prevention and research.
The PathMaker program is a stepping stone for students interested in a career in health sciences or STEM with backgrounds underrepresented in the biomedical workforce.
Study of Utah Lung Cancer Patients Finds Those Who Never Smoked May Have Genetic Predisposition for Cancer
Despite Utah's low smoking rate, lung cancer remains the leading cause of cancer death in Utah. In addition, lung cancer in people who have used tobacco and people who have never smoked behaves differently. Researchers at Huntsman Cancer Institute wanted to know why.
Huntsman Cancer Institute established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Howard Colman, MD, PhD is a physician-scientist specializing in the treatment of brain tumors and the diagnosis and management of neurologic complications of cancer.
The state of Huntsman Cancer Institute is strong and focused, according to CEO Mary Beckerle, PhD. The annual presentation to faculty, staff, and students is a chance for Dr. Beckerle to reflect on accomplishments of the prior year and outline priorities for the future.
Huntsman Cancer Institute established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Adam Cohen, MD, MS, was recently honored with a Huntsman Translational Scholar award. He is a researcher and physician, specializing in neuro-oncology and breast oncology.
Are you thinking about taking part in a clinical trial? Read these five frequently asked questions about clinical trials.
“Delivering Discoveries: Expanding the Reach of Precision Medicine,” was the theme of the American Society of Clinical Oncology (ASCO) 2018 annual meeting held June 1-5, 2018 in Chicago. One of the largest scientific conferences in the world, the meeting brings together nearly 40,000 attendees and features thousands of studies about new ways to prevent, detect, and treat cancer.
It is patients like you, your loved ones, and Dr. Gertz's parents who keep us motivated and excited to find ways to help in the fight against this terrible disease. We appreciate everything you do as patients—like donating samples and participating in clinical trials—and we want you to know that we are doing everything we can to help patients with breast and uterine cancer.
HCI established the Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Deborah Stephens, DO, was recently honored with a Huntsman Translational Scholar award. She is the physician leader of Hematology Clinical Trials at Huntsman Cancer Institute and is also an assistant professor in the Division of Hematology and Hematologic Malignancies at the University of Utah.
On May 16, 2018, HCI hosted a NASA astronaut and a team from the Center for the Advancement of Science in Space to discuss the opportunity of researching cancer in space.
HCI established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Theresa Werner, MD, was recently honored with a Huntsman Translational Scholar award. She is the medical director of Clinical Trials and treats patients with gynecologic cancers.
Huntsman Cancer Institute Opens Center for HOPE and is Awarded $9.7 Million to Improve Health Among Underserved Populations
Huntsman Cancer Institute (HCI) at the University of Utah (U of U) today announced the opening of the Cancer Population Sciences and Huntsman Center for Health Outcomes and Population Equity (HOPE), a new research and clinical space dedicated to preventing cancer and improving health among underserved populations and improving outcomes in cancer patients. The center recently received $9.7 million from the Patient-Centered Outcomes Research Institute (PCORI) to fund a clinical trial researching new and effective approaches to reduce tobacco use.
“Driving Innovative Cancer Science to Patient Care” was the theme of the American Association for Cancer Research (AACR) annual meeting, which took place April 14-18 in Chicago. Huntsman Cancer Institute (HCI) faculty and staff joined almost 22,000 other scientists, physicians, and patient advocates from around the world to share the latest findings in translational, clinical, and prevention-focused cancer research.